Hepatocellular Carcinoma in Asia: Physician and Patient Perspectives on Surveillance, Diagnosis, and Treatment
Journal of Gastrointestinal Cancer · 2024
DOI: 10.1007/s12029-024-01089-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastrointestinal Cancer, 2024. Verfasst von Rosmawati Mohamed und 12 weiteren Autor:innen. Beteiligte Einrichtung: University of Malaya, Kuala Lumpur, Malaysia. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
In several Asian countries, hepatocellular carcinoma (HCC) is a leading cause of cancer deaths. HCC risk factors in Asia differ from those elsewhere and are changing with the treatment landscape as systemic treatment options increase. This study was conducted to gain insight from physicians and patients into HCC screening, diagnosis, and treatment strategies in Indonesia, Korea, Malaysia, Singapore, Taiwan, Thailand, and Vietnam.
Methods
Two cross-sectional, anonymized, online surveys were completed between July and December 2022 by physicians diagnosing and treating HCC (55 questions on risk factors, surveillance, diagnosis, and treatment) and patients ≥ 18 years old diagnosed with HCC (36 questions on disease knowledge, quality of life, and experiences of diagnosis and treatment).
Results
Responses were received from 276 physicians in all 7 countries and 130 patients in Thailand, Taiwan, and Vietnam. From the physician’s perspective, surveillance programs are widespread but identify insufficient HCC cases; only 18% are early-stage HCC at diagnosis. From the patient’s perspective, knowledge of risk factors increases after diagnosis, but few seek support from patient associations; patients would benefit from better communication from their doctors. Treatment affordability and side effects are key issues for patients.
Conclusions
Awareness of the risk factors for HCC should be raised in primary care and the general population, and surveillance should identify early-stage HCC. Because patients rely on their doctors for support, doctors should better understand their patients’ needs, and patients could be supported by trained nurses or case managers. Programs are needed to increase patients’ access to proven HCC treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Malaya, Kuala Lumpur, Malaysia.
- Liver Disease Prevention and Treatment Research Foundation, Taipei, Taiwan.
- Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
- Faculty of Medicine, University Indonesia/Ciptomangunkusumo Hospital, Jakarta, Indonesia.
- Nuclear Medicine and Oncology Center, Bach Mai Hospital, Department of Nuclear Medicine, HaNoi Medical University, Hanoi, Vietnam.
- Department of Internal Medicine and Department of Gastroenterology, Asan Medical Centre, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Zitieren
APA
Mohamed, R., Wang, W., Tanwandee, T., Hasan, I., Pham, C. P., Lim, Y. S., Lu, S. N., Munisamy, M., Tran, T. T. H., Ratnawati, E., Sukeepaisarnjaroen, W., Karababa, M., & Tan, C. K. (2024). Hepatocellular Carcinoma in Asia: Physician and Patient Perspectives on Surveillance, Diagnosis, and Treatment. Journal of Gastrointestinal Cancer. https://doi.org/10.1007/s12029-024-01089-5
Vancouver
Mohamed R, Wang W, Tanwandee T, Hasan I, Pham CP, Lim YS, et al. Hepatocellular Carcinoma in Asia: Physician and Patient Perspectives on Surveillance, Diagnosis, and Treatment. Journal of Gastrointestinal Cancer. 2024. doi:10.1007/s12029-024-01089-5
BibTeX
@article{Mohamed2024,
author = {Mohamed, Rosmawati and Wang, Wendy and Tanwandee, Tawesak and Hasan, Irsan and Pham, Cam Phuong and Lim, Young-Suk and Lu, Sheng-Nan and Munisamy, Murallitharan and Tran, Thi Thanh Huong and Ratnawati, Evy and Sukeepaisarnjaroen, Wattana and Karababa, Mahir and Tan, Chee-Kiat},
title = {Hepatocellular Carcinoma in Asia: Physician and Patient Perspectives on Surveillance, Diagnosis, and Treatment},
journal = {Journal of Gastrointestinal Cancer},
year = {2024},
doi = {10.1007/s12029-024-01089-5}
}
EUVIMED